Nearly 6.7 million adults in the U.S. have heart failure, with prevalence expected to rise to 8.5 million by 20301,2. While heart failure is a chronic, progressive disease, advances in technology are ...

The CardioMEMS HF System is proven to significantly reduce heart failure hospitalizations and improve quality of life in NYHA class III HF patients St. Jude Medical now intends to exercise its ...

(RTTNews) - Abbott (ABT) said data from an investigator-sponsored European trial found managing indicated heart failure patients with CardioMEMS HF System resulted in a significant improvement in ...

MONITOR-HF is the third randomized, controlled trial globally to show a significant health benefit for indicated heart failure patients CardioMEMS is a paperclip-sized sensor that can remotely flag to ...

GAITHERSBURG, MD (updated) — A Food and Drug Administration (FDA) advisory committee narrowly voted in favor of a novel device that measures pulmonary-artery (PA) pressures in patients with heart ...

Mesa, Ariz.-based Tri-City Cardiology has added the CardioMEMS HF System following approval from CMS. The CardioMEMS system is a minimally invasive procedure that provides real-time monitoring of ...

Heart failure occurs when the heart can no longer pump enough blood and oxygen to support organs in the body. According to the Heart Failure Society of America, heart failure is a growing problem, ...

Abbott Laboratories, Inc. ABT has announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure who could benefit from advanced therapy ...

MARION — Congestive heart failure can be unpredictable and scary with little hope of living very long. One second you are on your feet and the next you’re in an ambulance on your way to the ER. But ...

Heart failure occurs when the heart can no longer pump enough blood and oxygen to support the organs in the body. According to the Heart Failure Society of America, heart failure is a growing problem, ...

Back in May, St. Jude Medical exercised its option to buy Atlanta-based startup, CardioMEMS, the moment the latter's product won FDA approval. The CardioMEMS HF system is the world’s first implantable ...